SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001485003-21-000013
Filing Date
2021-01-19
Accepted
2021-01-19 08:00:18
Documents
14
Period of Report
2021-01-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K sesn-20210119.htm   iXBRL 8-K 39560
  Complete submission text file 0001485003-21-000013.txt   185439

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sesn-20210119.xsd EX-101.SCH 2423
3 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sesn-20210119_cal.xml EX-101.CAL 710
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sesn-20210119_def.xml EX-101.DEF 1643
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sesn-20210119_lab.xml EX-101.LAB 24993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sesn-20210119_pre.xml EX-101.PRE 13190
7 EXTRACTED XBRL INSTANCE DOCUMENT sesn-20210119_htm.xml XML 11728
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 21533965
SIC: 2834 Pharmaceutical Preparations